Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
12 October 2012
IN THIS ISSUE
October issue
Pharmaceutical outsourcing
Regulatory cooperation
Improving Drug Delivery
News
 

Special Focus on Pharmaceutical Outsourcing
This month, in line with the recent ICSE trade show in Frankfurt, PTE Digital examines the challenges facing the pharmaceutical industry in the area of outsourcing, including why the future is positive for CROs and CMOs. More...
 
CROs and CMOs have Cause to celebrate
Respondents to an annual survey have reported good business and an increase in spending on pharmaceutical outsourcing services in 2012. Is this a sign of brighter times for the industry? More...
 
EMA Focuses on Greater International Cooperation
EMA’s most famous and most long-standing relationship is with the FDA, but in recent years the European regulator has also been working closely  with its counterparts in Japan. More...
 
Improving Drug Delivery with Cocrystals
Cocrystals can be used to improve the drug delivery of poorly soluble medicines. Our executive editor interviews an expert from Hovione to find out more about crystallization. More...
 
News Bites and Twitter Trends
If you’ve missed out on some of the top pharma news stories recently then our news roundup will update you. Highlights include Novo Nordisk’s expansion, Eli Lilly’s Warning Letter and European pharmacovigilance fees. More...

Key Topics:
Latest blog posts
Changing Industry Models at Work at CPhI
Compounding Crisis Spotlights Regulatory Confusion
Tracking Innovation in Drug Delivery at CPhI
More blog posts

Latest news
Merck Plans to Move Global Headquarters within New Jersey
Meningitis Outbreak Linked to Contaminated Vials of Steroid Injectables
Takeda to Acquire LigoCyte
More news

Upcoming events
European Pharmaceutical Pricing & Reimbursement (29–30 October | UK)
The New FDA/EU Aproach to Process Validation (30–31 October | Spain)
Virus and TSE Safety Made Simple (30–31 October | Spain)
More events

Products/Service Profiles
Agilent

Realize Effective Pharmaceuticals
Reliable solutions enable pharmaceutical scientists to innovate in disease research, accelerate drug discovery and have greater confidence throughout development and manufacturing. Agilent solutions in genomics research, automation, separation and detection technologies along with workflow driven software solutions helps deliver the answers to bring effective therapeutics to market.
Learn more at www.agilent.com/lifesciences/realizepharma

 
Agilent

Agilent ICP-MS/ICP-OES
Reliable solutions for regulated pharmaceutical laboratories

Complying with new elemental impurity limits as defined by draft USP methods <232>/<233> could pose a significant challenge. You need to choose qualified hardware and software, ensure verification, and maintain electronic records. But there is a simple answer – Request a free copy of our primer on Elemental Impurity Analysis to learn more.

 
Celanese

Learn more about VitalDose® EVA excipients on the VitalDose blog.
Learn how EVA polymers have been used for years in controlled release pharmaceutical and medical device applications. Read more

 
Shimadzu

The Nexera MP UHPLC for LC/MS analysis in drug detection processes
Shimadzu has introduced the Nexera MP UHPLC as a Front End system for LC/MS. The Nexera MP is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes. Read more


Special Supplement
BASF

Solubilization Solutions
In a special PharmTech issue, current and emerging bioavailability challenges are examined. Articles address solutions and approaches for solubilization as related to solid dispersions by hot-melt extrusion, lipophilic excipients, lipid-based formulations, spray drying, and more.
Read more

 
Survey
The European Generic Medicines Agency has recently claimed that the potential fees to be charged by the European Medicines Agency for pharmacovigilance activities are unjustifiably high. Do you agree?
 
Yes 89%
 
 
No  8%
     
 
The wording of the fees is not clear  3%

This week we would like to know...

Do you think the growing number of anticounterfeiting technologies technologies, coupled with increased focus from regulators, have had a positive impact on reducing the number of counterfeit pharmaceuticals in the legal supply chain?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.